Skip to content
Skip to navigation menu

Cymraeg

Cardiff University honoured for Chinese cancer partnership

19 October 2010

The Vice-Chancellor of Cardiff University, Dr David Grant, has been honoured by China’s Capital Medical University in recognition of two institutions’ pioneering cancer research partnership.

Cardiff and Capital Medical have been working together for several years on new approaches to breast and prostate cancer. In 2007, a formal agreement was signed for Capital Medical researchers to come to Cardiff’s Medical School and work with Professor Wen Jiang, from China’s Shandong province and one of the world’s leading cancer researchers.

Since the agreement, six Capital Medical research fellows have come to Cardiff and 14 papers have been written for conferences and journals as a result. The researchers have been working on the metastasis of breast and prostate cancer – how the disease spreads around the body from the original tumour.

Now Capital Medical University has made Dr Grant an international adviser – the first person from the UK to be honoured in this way. The only other recipients of this prestigious honour have been former German Chancellor Gerhard Schröder and Professor Tomas Hökfelt, Professor Emeritus at Sweden’s Karolinska Institute.

The ceremony was held in the Great Hall of Capital Medical University, attended by representatives of the British Embassy and the British Council in China. Dr Grant received the award from the Chairperson of the Board at Capital Medical University, Li Ming.

A further agreement has also been signed between the two Universities, allowing for 20 more scholars to come to Cardiff over the next four years. The arrangement has been funded by Albert Hung, the Hong Kong-based entrepreneur and philanthropist, who has supported many joint initiatives between Cardiff and Chinese medical scientists.

Dr Grant said of his award: "I view this as an acknowledgement of the excellent work between our two institutions that has taken place to date. The visiting scholars programme between Cardiff and Capital Medical is a very good example of where international activities can be of great benefit in tackling global issues. The rising occurrence of breast cancer in China is a major issue. By pooling research expertise and sharing knowledge we can build upon the existing knowledge and make real progress."

The honour came as part of a successful visit by a high-level Cardiff team, building on the University’s many strong partnerships in China. Senior researchers from Cardiff Medical School spoke at the Capital International Cancer Conference for 2010. Professor Jiang will spoke on metastasis while the other speakers were:

Professor Malcolm Mason – new developments in radiation treatment of prostate cancer
Professor Paul Morgan (Dean, Cardiff School of Medicine) – the role of the complement system in cancer
Professor Robert Mansel – Research into sentinel node biopsy, which is now saving many breast cancer patients from unnecessary surgery.

ENDS

For further information please contact:

Stephen Rouse,
Public Relations Office,
Cardiff University.
029 2087 5596
E-mail: RouseS@cardiff.ac.uk

Cardiff University
Cardiff University is recognised in independent government assessments as one of Britain’s leading teaching and research universities and is a member of the Russell Group of the UK’s most research intensive universities. Among its academic staff are two Nobel Laureates, including the winner of the 2007 Nobel Prize for Medicine, Professor Sir Martin Evans. Founded by Royal Charter in 1883, today the University combines impressive modern facilities and a dynamic approach to teaching and research. The University’s breadth of expertise in research and research-led teaching encompasses: the humanities; the natural, physical, health, life and social sciences; engineering and technology; preparation for a wide range of professions; and a longstanding commitment to lifelong learning. Visit the University website at: www.cardiff.ac.uk